Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease

Alimentary Pharmacology & Therapeutics

Volumn 8, Issue 1, 1994, Pages 35-43

  CAPRILLI, R ^a   ANDREOLI, A ^b   CAPURSO, L ^c   CORRAO, G ^d   ALBASIO, G D ^e   GIOIENI, A ^f   ASSUERO LANFRANCHI, G ^g   PALADINI, I ^h   PALLONE, F ⁱ   PONTI, V ^j   RIGO, G P ^k   ROSSINI, F P ^j   STURNIOLO, G C ^l   TONELLI, F ^h   VALPIANI, D ^m  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d Ospedale di Careggi ^*  (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^j MOLINETTE HOSPITAL   (Italy)

^k UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^l UNIVERSITY OF PADOVA   (Italy)

^m MORGAGNI PIERANTONI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; ENDOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AMINOSALICYLIC ACIDS; CROHN DISEASE; FEMALE; HUMANS; MALE; MESALAMINE; MIDDLE AGED; RECURRENCE;

EID: 0028264154     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1994.tb00158.x     Document Type: Article

References (31)

1. Recurrence after surgery in Crohn's disease
2. Recurrence of Crohn's disease after primary excisional surgery
3. Endoscopic lesions in Crohn's disease early after ileocecal resection
4. Predictability of the postoperative course of Crohn's disease
5. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms
6. Postoperative recurrence of Crohn's disease in relation radicality of operation and sulfasalazine prophylaxis: a multicenter trial
7. Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease
8. and the G.E.T.A.I.D. Placebo controlled trial of Claversal in the prevention of early endoscopic relapse after ‘curative’ resection for Crohn's disease (CD)
9. Rederived values of eight coefficients of the Crohn's disease activity index (CDAI)
10. 5‐ASA in the prevention of Crohn's disease postoperative recurrence
11. European cooperative Crohn's disease study (ECCDS): results of drug treatment
12. Natural history of recurrent Crohn's disease at the ielocolonic anastomosis after curative surgery
13. Tables of the numbers of patients required in clinical trials using the LOG‐RANK test
14. Evaluation of survival data and two new rank order statistics arising in its consideration
15. A placebo controlled trial of metronidazole for recurrence prevention of Crohn's disease after resection of the terminal ileum
16. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation
17. Perforating and non‐perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms
18. Prevention of Crohn's disease recurrences after intestinal resection with Eudragit‐L‐coated 5‐aminosalicylic acid
19. and the Italian IBD group
20. Measurement of gastrointestinal pH profiles in normal ambulant human subjects
21. Concentration of 5‐ASA and Ac‐5‐ASA in human ileocolonic biopsy homogenates after oral 5‐ASA preparations
22. Effects of 5‐aminosalicylic acid, 4‐ASA, N‐acetyl‐5‐ASA and sulfapyridine on FMET‐LEU‐PHE induced ileitis in rats
23. Salicylates used in inflammatory bowel disease and colchicine impair interferon‐y induced HLA‐DR expression
24. Inhibition of antibody secretion by 5‐aminosalicylic acid
25. Chemotactic activity in inflammatory bowel disease: role of leukotriene B4
26. Chemotactic peptide stimulation of leukotrienes from health and inflamed rabbit colons
27. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine and 5‐aminosalicylic acid
28. Inhibition of 5‐lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulphasalazine and 5‐aminosalicylic acid
29. 5‐AminosalicyIic acid, a cofactor for colonic prostacyclin synthesis